RAB8 Human

RAB8, Member RAS Oncogene Family Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to RAB8 Human

RAB8 Human (RAB8A) is a small GTPase protein encoded by the RAB8A gene on chromosome 19p13.1. It belongs to the RAS superfamily and shares 97% similarity with dog RAB8 and 96% with mouse MEL . Structurally, it contains conserved GTP/GDP-binding domains (G1–G5 loops) and a C-terminal CAAX motif, which distinguishes it from most RAB proteins . RAB8A is critical for intracellular vesicular transport, particularly in polarized cells, and regulates dynamic membrane recycling pathways .

Functional Roles of RAB8 Human

RAB8A governs membrane trafficking processes, including:

  • Vesicular Transport: Mediates protein delivery from the trans-Golgi network to basolateral plasma membranes in epithelial cells and dendritic surfaces in neurons .

  • Membrane Recycling: Collaborates with Arf6, EHD1, Myo5, and Rab11 to regulate cell surface domain formation .

  • Ciliogenesis and Cell Morphogenesis: Essential for primary cilium formation and actin-based protrusion dynamics .

ProcessKey PartnersOutcomes
Basolateral TransportRab8ip/GC KinaseVesicle targeting/fusion regulation
CiliogenesisIFT proteinsCilium assembly and signaling
Cholesterol EffluxABCA1, ApoA-IFoam cell formation in atherosclerosis

Regulation and Interactions

RAB8A activity is tightly regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs):

  • GEFs: Rabin8 (Rabin3 homolog) activates RAB8A by promoting GTP binding, enabling membrane trafficking to protrusive structures . MSS4, a GEF for RAB8/3/5/8/10/14, also facilitates nucleotide exchange .

  • Effectors:

    • Rab8ip/GC Kinase: Phosphorylates substrates like myelin basic protein, linking RAB8A to stress responses .

    • Optineurin: Regulates vesicle dynamics and autophagy .

    • MAP4K2: Modulates actin cytoskeleton remodeling .

Role in Disease and Pathology

RAB8A is implicated in cancer, metabolic disorders, and neurodegeneration:

  • Cancer:

    • NSCLC: RAB8A regulates Klotho surface expression, inhibiting Wnt-β-catenin signaling and tumor growth .

    • EGFR-TKI Resistance: Hyperactivation of RAB8/Rabin8 promotes FGF secretion, driving tumor formation in C. elegans models .

  • Atherosclerosis:

    • Cholesterol Efflux: RAB8A upregulation in macrophages facilitates cholesterol removal via ABCA1, mitigating foam cell formation .

    • Lipid-Loaded Macrophages: Induce RAB8A expression, redistributing cholesterol to lamellipodia and membrane ruffles .

Table 1: RAB8A vs. RAB8B Functional Specificity

FunctionRAB8ARAB8B
Apical TransportEssentialNot Required
Basolateral TransportLimited RolePrimary Role
CiliogenesisCriticalCritical (Synergistic)

Source:

Table 2: RAB8A Interactions and Pathways

PartnerInteraction TypeFunctional Outcome
Rabin8GEFActivation, polarized transport
Rab8ip/GC KinaseEffectorStress response, vesicle fusion
OptineurinEffectorAutophagy, vesicle dynamics

Sources:

Product Specs

Introduction
RAB8, a member of the RAS oncogene family (RAB8B), is a small GTPase found on the surfaces of membrane-bound organelles within the cytoplasm. It plays a crucial role in various cellular processes, including the targeted transport of vesicles, the release of neurotransmitters, and the regulation of cell junction dynamics in Sertoli cells. RAB proteins, including RAB8, facilitate intracellular vesicle transport by enabling the precise docking and fusion of vesicles with their intended target membranes.
Description
Recombinant human RAB8, produced in E. coli, is a single polypeptide chain consisting of 227 amino acids (residues 1-204) with a molecular weight of 25.7 kDa. This protein is engineered with a 23 amino acid His-tag at the N-terminus to facilitate purification using proprietary chromatographic methods.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
The RAB8 solution is provided at a concentration of 1 mg/ml and contains 20 mM Tris-HCl buffer (pH 8.0), 0.4 M urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep the solution refrigerated at 4°C. For longer storage, freeze the solution at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for extended storage. Repeated freezing and thawing of the solution should be avoided.
Purity
Purity exceeds 90% as determined by SDS-PAGE analysis.
Synonyms
Ras-related protein Rab-8B, RAB8B.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMAKTYDY LFKLLLIGDS GVGKTCLLFR FSEDAFNTTF ISTIGIDFKI RTIELDGKKI KLQIWDTAGQ ERFRTITTAY YRGAMGIMLV YDITNEKSFD NIKNWIRNIE EHASSDVERM ILGNKCDMND KRQVSKERGE KLAIDYGIKF LETSAKSSAN VEEAFFTLAR DIMTKLNRKM NDSNSAGAGG PVKITENRSK KTSFFRC.

Q&A

What is RAB8A and what are its primary cellular functions?

RAB8A is a small GTPase belonging to the Rab family of proteins that function as key regulators of intracellular membrane trafficking. It cycles between an inactive GDP-bound form and an active GTP-bound form that recruits different downstream effectors responsible for vesicle formation, movement, tethering, and fusion . RAB8A localizes to endosomal recycling compartments together with RAB11 and ARF6 to promote polarized transport of newly synthesized proteins and mediate protrusion formation and cell shape remodeling . It plays essential roles in polarized vesicular trafficking, neurotransmitter release, and maintenance of cell polarity in various cell types, including intestinal epithelial cells where it regulates the localization of apical proteins .

How does RAB8A differ from RAB8B and other RAB family proteins?

RAB8 has two isoforms in mammals: RAB8A and RAB8B, encoded by different genes. While RAB8A is ubiquitously expressed across tissues, RAB8B shows a more restricted expression pattern, predominately found in brain, spleen, and testes . Despite sharing sequence homology with other RAB proteins, RAB8A has distinct cellular functions and tissue distribution patterns. Unlike some other RAB proteins that may specialize in certain trafficking pathways, RAB8A participates in multiple cellular processes including vesicle recycling, polarized trafficking, and immune cell functions such as T cell receptor docking at the immune synapse .

What experimental models are commonly used to study RAB8A function?

The most widely used experimental models to study RAB8A function include:

  • Cell culture systems: Human cell lines expressing wild-type, constitutively active, or dominant-negative forms of RAB8A

  • Conditional knockout mouse models: B cell-specific RAB8A knockout mice have been particularly valuable for studying its role in immune responses

  • CRISPR-Cas9 gene editing: For creating cell lines with specific RAB8A mutations

  • Fluorescently-tagged RAB8A constructs: For live-cell imaging studies tracking vesicle movement and protein interactions

Selection of the appropriate model depends on the specific research question. For investigating RAB8A's role in immune function, B cell-specific knockout mice have proven valuable, demonstrating that loss of RAB8A leads to increased antibody responses and class-switch recombination .

What are the recommended methods for detecting and quantifying RAB8A protein levels?

Several methods can be employed to detect and quantify RAB8A protein:

MethodApplicationAdvantagesLimitations
Western BlotProtein expressionSemi-quantitative, widely accessibleLess precise quantification
ELISAProtein quantificationHigh sensitivity (down to 0.056 ng/ml), specific for human RAB8AMore expensive, requires specialized kits
ImmunofluorescenceProtein localizationVisualizes subcellular distributionQualitative rather than quantitative
Flow CytometrySingle-cell analysisHigh-throughput, quantitativeRequires cell permeabilization
Mass SpectrometryProteomic analysisCan identify post-translational modificationsComplex sample preparation, expensive

For precise quantification in human samples, the Human Ras-related protein Rab-8A (RAB8A) ELISA Kit offers high sensitivity with a detection range of 0.156-10 ng/mL and sensitivity of 0.056 ng/ml . This assay shows good reproducibility with intra-assay CV of 5.8% and inter-assay CV of 9.3% . When studying cellular distribution patterns, immunofluorescence microscopy with antibodies against RAB8A remains the gold standard.

How can researchers effectively manipulate RAB8A expression or activity in experimental systems?

To manipulate RAB8A expression or activity, researchers can employ several strategies:

  • Genetic approaches:

    • siRNA or shRNA for transient or stable knockdown

    • CRISPR-Cas9 for gene knockout or knock-in of specific mutations

    • Overexpression of wild-type RAB8A using plasmid transfection or viral transduction

  • Protein activity manipulation:

    • Expression of constitutively active (GTP-locked) RAB8A mutants (e.g., Q67L)

    • Expression of dominant-negative (GDP-locked) RAB8A mutants (e.g., T22N)

    • Small molecule inhibitors targeting RAB8A GEFs or GAPs

  • Conditional systems:

    • Cre-loxP systems for tissue-specific deletion (as used in B cell-specific Rab8a knockout models)

    • Tetracycline-inducible expression systems for temporal control

When designing experiments to study RAB8A function, it is important to include appropriate controls and validation steps, such as confirming knockdown/knockout efficiency by Western blot or qPCR, and assessing potential compensatory upregulation of RAB8B or other related proteins.

What are the key considerations when studying RAB8A interactions with effector proteins?

When investigating RAB8A interactions with effector proteins, researchers should consider:

  • Activation state specificity: Most effectors interact specifically with the GTP-bound form of RAB8A, so using constitutively active mutants can facilitate detection of these interactions

  • Methodological approaches:

    • Co-immunoprecipitation assays for endogenous protein interactions

    • GST-pulldown assays using recombinant RAB8A proteins

    • Yeast two-hybrid screens for novel interaction partners

    • Proximity labeling methods (BioID, APEX) to identify spatial interactions

    • FRET/BRET assays for dynamic interaction studies in living cells

  • Localization context: Since RAB8A functions in multiple cellular compartments, determining the subcellular location of interactions is crucial using co-localization immunofluorescence

  • Competitive binding: Multiple effectors may compete for binding to active RAB8A, so quantitative binding studies can reveal hierarchies of interactions

When reporting interaction studies, researchers should clearly specify the activation state of RAB8A used, the cellular context, and validate interactions through multiple complementary methods to ensure reliability of findings.

How does RAB8A contribute to immune cell function, particularly in B lymphocytes?

RAB8A plays significant roles in B lymphocyte function, with recent research revealing unexpected immunoregulatory effects:

  • Antibody production: Loss of RAB8A in B cells leads to increased antibody responses both in vitro and in vivo, suggesting a negative regulatory role

  • Class-switch recombination (CSR): B cell-specific Rab8a knockout mice show enhanced CSR, with increased AID (activation-induced deaminase) expression and elevated IgG2b and IgG2c isotypes

  • Signaling pathway modulation: The absence of RAB8A alters cellular signaling, particularly the PI3K/AKT/mTOR pathway, which influences AID expression and CSR

  • Antigen processing: RAB8A strongly colocalizes with internalized antigen along the antigen processing route, suggesting involvement in antigen trafficking, though knockout studies did not reveal defects in BCR trafficking or antigen presentation

  • Basal antibody production: Rab8a KO mice exhibit slightly increased basal serum IgM and IgE levels with decreased IgG1, while other isotypes remain unchanged

For researchers studying these phenomena, experimental approaches should include:

  • In vivo immunization models with T-dependent and T-independent antigens

  • Analysis of antibody responses by isotype-specific ELISA

  • In vitro class-switch recombination assays

  • Flow cytometric analysis of B cell activation markers

  • Analysis of signaling pathway activation using phospho-specific antibodies

What experimental approaches can reveal RAB8A's role in cell polarity and membrane trafficking?

To investigate RAB8A's functions in cell polarity and membrane trafficking, researchers should consider these methodological approaches:

  • Live-cell imaging techniques:

    • TIRF microscopy to visualize membrane-proximal vesicle movement

    • Spinning disk confocal microscopy for high-speed tracking of vesicle dynamics

    • Photoactivatable or photoconvertible RAB8A fusions to track specific vesicle pools

  • Cargo trafficking assays:

    • Surface biotinylation and internalization assays to measure endocytosis rates

    • Secretion assays using reporter proteins (e.g., Gaussia luciferase) to quantify exocytosis

    • RUSH system (Retention Using Selective Hooks) to synchronize and measure cargo delivery times

  • Cell polarity readouts:

    • Quantification of apical vs. basolateral protein distribution in epithelial cells

    • Measurement of directed migration in wound healing assays

    • Analysis of neuronal polarity in primary neurons (axon vs. dendrite specification)

  • Correlative light and electron microscopy (CLEM):

    • To characterize the ultrastructure of RAB8A-positive compartments

    • Particularly useful for studying specialized structures like primary cilia

These approaches, combined with genetic manipulation of RAB8A expression or activity, can provide mechanistic insights into how RAB8A coordinates membrane trafficking events and maintains cell polarity across different cellular contexts.

How can researchers investigate the differential roles of RAB8A's nucleotide-bound states?

RAB8A cycles between inactive (GDP-bound) and active (GTP-bound) states, which determine its functional properties. To investigate the specific functions of these different states:

  • Expression of nucleotide-binding mutants:

    • Constitutively active mutants (e.g., Q67L) that remain GTP-bound

    • Dominant negative mutants (e.g., T22N) that remain GDP-bound

    • These can be expressed using transient transfection, stable cell lines, or inducible systems

  • Active RAB8A pulldown assays:

    • GST-fused effector domains (such as MICAL-L3) specifically bind GTP-bound RAB8A

    • These can be used to quantify the proportion of active RAB8A under different conditions

  • FRET-based activity sensors:

    • Intramolecular FRET sensors that change conformation upon GTP binding

    • Allow real-time monitoring of RAB8A activation in living cells

  • Optogenetic approaches:

    • Light-controlled activation of RAB8A or its GEFs

    • Enables spatiotemporal precision in activating RAB8A in specific cellular regions

  • Cryo-electron microscopy:

    • Structural analysis of RAB8A in different nucleotide-bound states

    • Reveals conformational changes that mediate effector binding

What is known about RAB8A dysregulation in human diseases?

RAB8A dysregulation has been implicated in several human pathologies:

  • Neurodegenerative disorders:

    • Altered RAB8A function contributes to defective protein trafficking in Huntington's disease

    • RAB8A may be involved in α-synuclein clearance pathways relevant to Parkinson's disease

  • Cancer:

    • Aberrant RAB8A expression has been reported in several cancer types

    • May contribute to tumor invasiveness by regulating membrane trafficking pathways involved in cell migration

  • Immunological disorders:

    • The finding that RAB8A deficiency in B cells leads to increased antibody responses suggests potential involvement in autoimmune conditions or hypersensitivity disorders

    • RAB8A's role in TLR signaling in macrophages implicates it in inflammatory processes

  • Ciliopathies:

    • RAB8A is essential for primary cilium formation and maintenance

    • Defects in this process are linked to ciliopathies like Bardet-Biedl syndrome

When investigating RAB8A in disease contexts, researchers should consider both expression level changes and functional alterations, including mutations, post-translational modifications, or mislocalization. Correlation with clinical outcomes and integration with other disease biomarkers can provide insights into the significance of RAB8A alterations.

How can advanced techniques help characterize RAB8A's interactome in different cellular contexts?

Understanding RAB8A's interactome across different cellular contexts requires sophisticated proteomic approaches:

  • Proximity-based labeling methods:

    • BioID: Fusion of RAB8A with a biotin ligase to biotinylate proximal proteins

    • APEX2: Peroxidase-based labeling of nearby proteins

    • TurboID: Faster biotin ligase variant for short-timeframe interactions

    • These approaches can identify context-specific interactors in living cells

  • Quantitative interaction proteomics:

    • SILAC or TMT labeling combined with immunoprecipitation

    • Label-free quantitative mass spectrometry

    • iBAQ or other absolute quantification methods to determine stoichiometry of interactions

  • Crosslinking mass spectrometry (XL-MS):

    • Captures transient interactions through chemical crosslinking

    • Provides structural information about interaction interfaces

  • Tissue-specific interactome analysis:

    • Cell type-specific expression of tagged RAB8A in vivo

    • Analysis of interactors in primary cells isolated from different tissues

TechniqueTemporal ResolutionSpatial InformationAdvantagesLimitations
BioIDHours (12-24h)Compartment-levelWorks in living cellsSlow labeling kinetics
TurboIDMinutes (10-30m)Compartment-levelRapid labelingMay have higher background
APEX2Minutes (1m)Nanometer precisionHigh spatial resolutionRequires exogenous biotin-phenol
XL-MSSnapshotAtomic-level contactsStructural informationComplex data analysis
IP-MSSnapshotNoneEstablished protocolsMay lose weak interactions

These approaches can reveal how RAB8A's interaction network changes during cell differentiation, activation states, or disease conditions, providing a dynamic view of its functional roles across contexts.

What are the challenges and solutions in studying RAB8A in primary human samples?

Investigating RAB8A in primary human samples presents several challenges:

  • Sample availability and preparation:

    • Limited material from biopsies or blood samples

    • Heterogeneity of cell populations

    • Solution: Single-cell analysis techniques, laser capture microdissection for specific cell types, or magnetic sorting for enrichment of target populations

  • Low endogenous expression levels:

    • RAB8A may be expressed at levels below detection limits of standard methods

    • Solution: Use highly sensitive detection methods like droplet digital PCR for mRNA quantification or highly sensitive ELISA kits (detection limit of 0.056 ng/ml) for protein measurement

  • Distinguishing RAB8A activation states:

    • Standard antibodies cannot differentiate between GDP- and GTP-bound forms

    • Solution: Active RAB8A pulldown assays using effector binding domains or phospho-specific antibodies that correlate with activation

  • Preserving native protein interactions:

    • Interactions may be lost during sample processing

    • Solution: In situ proximity labeling prior to sample processing, or rapid crosslinking of fresh samples

  • Genetic manipulation limitations:

    • Difficult to perform genetic manipulation in primary samples

    • Solution: Ex vivo culture systems with adenoviral or lentiviral delivery of constructs, or use of patient-derived cells with natural RAB8A variants

For clinical samples specifically, researchers should consider using the Human Ras-related protein Rab-8A ELISA Kit, which offers high sensitivity for measuring RAB8A in serum, plasma, and cell culture supernatants . When collecting and processing samples, standardized protocols should be established to minimize technical variation that could obscure biological differences.

What are the emerging technologies that could advance RAB8A research?

Several cutting-edge technologies show promise for advancing RAB8A research:

  • CRISPR base editing and prime editing:

    • Enables precise introduction of specific RAB8A mutations without double-strand breaks

    • Useful for modeling disease-associated variants or creating separation-of-function mutants

  • Optogenetic and chemogenetic tools:

    • Light- or small molecule-inducible RAB8A activation systems

    • Allows temporal and spatial control of RAB8A function in specific cellular compartments

  • Super-resolution microscopy:

    • STED, PALM, STORM, and expansion microscopy

    • Resolves RAB8A-positive vesicles and their dynamics below the diffraction limit

    • Especially valuable for studying crowded trafficking hubs

  • Organoid systems:

    • 3D culture models that better recapitulate tissue architecture

    • Particularly relevant for studying RAB8A's role in epithelial polarization and specialized cell types

  • Single-molecule imaging:

    • Tracks individual RAB8A molecules in living cells

    • Reveals stochastic events and rare subpopulations that bulk measurements miss

  • Cryo-electron tomography:

    • Visualizes RAB8A and associated complexes in their native cellular environment

    • Provides structural insights at macromolecular resolution

These technologies can address longstanding questions about RAB8A's precise localization, activation dynamics, and functional interactions in complex cellular environments.

How does RAB8A coordinate with other RAB proteins in membrane trafficking networks?

RAB8A functions within a complex network of RAB proteins that coordinate sequential steps in membrane trafficking:

  • RAB cascades:

    • RAB8A operates downstream of RAB11 in recycling endosome to plasma membrane transport

    • This sequential activation is mediated by shared effectors or GEFs

    • Experimental approach: Simultaneous live imaging of differently colored RAB proteins to track compartment maturation

  • Compartment identity regulation:

    • RAB8A contributes to the identity of specific membrane domains

    • Often works with RAB11 and ARF6 in recycling endosomes

    • Research technique: Correlative light and electron microscopy to define precise membrane domain characteristics

  • Effector sharing and competition:

    • Some effectors can bind multiple RABs, creating functional overlap

    • For example, MICAL-L3 can interact with both RAB8A and RAB13

    • Methodological approach: Quantitative binding assays to determine affinity hierarchies

  • Compensation mechanisms:

    • RAB8B may compensate for RAB8A loss in some contexts

    • This explains why some RAB8A knockout phenotypes are milder than expected

    • Research strategy: Double knockout studies or acute protein degradation approaches to overcome compensation

To study these coordination mechanisms, researchers should consider multiplexed imaging approaches, systems biology modeling of RAB networks, and quantitative proteomic analysis of RAB microdomains. Understanding these networks will provide insights into how cells maintain robustness in membrane trafficking despite perturbations.

What insights can integrative multi-omics approaches provide about RAB8A function?

Integrative multi-omics approaches can reveal comprehensive insights into RAB8A function by connecting different layers of biological information:

  • Transcriptomics-proteomics integration:

    • RNA sequencing data from RAB8A knockout models reveals changes in gene expression profiles

    • Proteomics identifies changes in protein abundance and post-translational modifications

    • Integration reveals regulatory relationships and feedback mechanisms

    • Example finding: RNAseq from Rab8a KO B cells showed increased activation-induced deaminase (AID) expression, supporting the observation of enhanced class-switch recombination

  • Spatial transcriptomics and proteomics:

    • Maps the expression and localization of RAB8A and its effectors across tissue regions

    • Particularly valuable for understanding tissue-specific functions

  • Metabolomics integration:

    • Connects RAB8A trafficking functions to metabolic consequences

    • Especially relevant for nutrient transporters that may be RAB8A cargo

  • Single-cell multi-omics:

    • Captures heterogeneity in RAB8A expression and function across cell populations

    • Can reveal rare cell states or transition events

  • Network analysis across datasets:

    • Constructs functional networks connecting RAB8A to diverse cellular processes

    • Identifies central nodes that might serve as intervention points

When designing multi-omics studies, researchers should collect samples for different analyses from the same biological material when possible to facilitate integration. Computational approaches like weighted gene correlation network analysis (WGCNA) can help identify modules of co-regulated genes and proteins that may represent functional units in RAB8A-regulated processes.

Product Science Overview

Introduction

RAB8A, also known as RAB8, is a member of the RAS oncogene family. It is a small GTPase that plays a crucial role in intracellular membrane trafficking. This protein is involved in the transport of proteins from the endoplasmic reticulum (ER) to the Golgi apparatus and the plasma membrane .

Gene and Protein Structure

The RAB8A gene is located on chromosome 19p13.1 in humans . The protein encoded by this gene is approximately 200 amino acids in length and shares significant similarity with other RAB/YPT family proteins. It contains four GTP/GDP-binding sites, which are characteristic of RAS proteins .

Function

RAB8A is involved in various cellular processes, including vesicle formation, movement, tethering, and fusion. It cycles between an inactive GDP-bound form and an active GTP-bound form. In its active form, RAB8A recruits different sets of downstream effectors that are directly responsible for vesicle formation and trafficking .

Pathways and Interactions

RAB8A is associated with several cellular pathways, including the regulation of trafficking and the organization of interphase microtubules. It has been shown to interact with proteins such as Optineurin and MAP4K2, which are involved in cellular morphogenesis and other processes .

Clinical Significance

Mutations or dysregulation of RAB8A have been linked to various diseases, including congenital diarrhea and iritis . Despite being isolated as a transforming gene from a melanoma cell line, no direct linkage between RAB8A and malignant melanoma has been demonstrated .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.